enVVeno Medical Corporation’s recent filing unveils that its Chief Executive Officer BERMAN ROBERT ANDREW acquired Company’s shares for reported $30600.0 on Dec 19 ’24. In the deal valued at $2.55 per share,12,000 shares were bought. As a result of this transaction, BERMAN ROBERT ANDREW now holds 222,236 shares worth roughly $0.55 million.
Then, Alavi Hamed sold 8,334 shares, generating $51,837 in total proceeds. Upon selling the shares at $6.22, the Chief Technology Officer now owns 0 shares.
Price Performance Review of NVNO
On Friday, enVVeno Medical Corporation [NASDAQ:NVNO] saw its stock fall -1.58% to $2.49. Over the last five days, the stock has lost -12.63%. enVVeno Medical Corporation shares have fallen nearly -51.56% since the year began. Nevertheless, the stocks have fallen -45.51% over the past one year. While a 52-week high of $6.97 was reached on 02/29/24, a 52-week low of $2.51 was recorded on 12/20/24. SMA at 50 days reached $3.22, while 200 days put it at $4.62.
Levels Of Support And Resistance For NVNO Stock
The 24-hour chart illustrates a support level at 2.38, which if violated will result in even more drops to 2.27. On the upside, there is a resistance level at 2.67. A further resistance level may holdings at 2.85. The Relative Strength Index (RSI) on the 14-day chart is 23.71, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.24%. Stochastics %K at 3.55% indicates the stock is a buying.
How much short interest is there in enVVeno Medical Corporation?
A steep rise in short interest was recorded in enVVeno Medical Corporation stocks on 2024-11-29, dropping by 28817.0 shares to a total of 0.48 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 0.51 million shares. There was a decline of -6.02%, which implies that there is a negative sentiment for the stock.
